Skip to content
healthcare.dev

Gemcitabine

NDC 0409-0186, GEMCITABINE, injection, powder, lyophilized, for solution, from Hospira, Inc..

Product NDC
0409-0186
Status
Listed
Labeler
Hospira, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078339
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0409-0186 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GEMCITABINE HYDROCHLORIDE38 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
0409-0186-01004090186011 VIAL, SINGLE-DOSE in 1 CARTON (0409-0186-01) / 25 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d16907e7-a8c8-4039-ace4-cf4e24ba68c0
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0409-0186

Use it

Look up 0409-0186 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0409-0186 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0409-0186. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.